Locally Advanced Unresectable Vaginal Melanoma: Response With Anti-Programmed Death Receptor 1

J Low Genit Tract Dis. 2016 Jan;20(1):e4-5. doi: 10.1097/LGT.0000000000000168.
No abstract available

Publication types

  • Case Reports

MeSH terms

  • Aged
  • Antibodies, Monoclonal / administration & dosage
  • Antibodies, Monoclonal, Humanized / administration & dosage
  • Antineoplastic Agents / administration & dosage*
  • Female
  • Humans
  • Imatinib Mesylate / administration & dosage
  • Immunologic Factors / administration & dosage*
  • Immunotherapy / methods*
  • Infusions, Intravenous
  • Ipilimumab
  • Melanoma / diagnosis
  • Melanoma / pathology
  • Melanoma / therapy*
  • Programmed Cell Death 1 Receptor / antagonists & inhibitors*
  • Treatment Outcome
  • Vaginal Neoplasms / diagnosis
  • Vaginal Neoplasms / pathology
  • Vaginal Neoplasms / therapy*

Substances

  • Antibodies, Monoclonal
  • Antibodies, Monoclonal, Humanized
  • Antineoplastic Agents
  • Immunologic Factors
  • Ipilimumab
  • Programmed Cell Death 1 Receptor
  • Imatinib Mesylate
  • pembrolizumab